David Meehan

DAVID MEEHAN advises public and private companies, as well as private equity sponsors and their portfolio companies, in a variety of transactions, including mergers and acquisitions, divestitures, recapitalizations, and minority investments. Among other things, David has extensive experience in lower-to-middle market private equity transactions and often provides general corporate counseling, advising on commercial contracts, executive employment and incentive arrangements, management agreements, corporate governance, and other general transaction related matters. David’s experience spans transactions ranging from valuations of $1 million to well over $100 million and includes a range of industries, such as technology, healthcare, and manufacturing.

David graduated summa cum laude from the Indiana University Robert H. McKinney School of Law, where he served as editor-in-chief of the Indiana Law Review. David also graduated with a Master in Business Administration, major in finance, from the Indiana University Kelley School of Business. Prior to attending law school, David worked as special assistant to former Indiana Governor Mitch Daniels and as a policy analyst at the Indiana Economic Development Corporation. 

Recent transactions on which David has advised include:

• Advised MarcyPen Capital Partners (MarcyPen) as lead investor, together with Brand Velocity Group (BVG), in a growth investment in The GLD Shop (GLD), a globally recognized jewelry brand.

• TIDI Products, a portfolio company of RoundTable Healthcare Partners, in its sale to middle-market private equity firm, TJC, L.P.

• SunOpta, Inc. (NASDAQ:STKL) (TSX:SOY) in its US$141 million sale of its frozen fruit operations to Canadian-based frozen food manufacturer, Nature’s Touch.
• Avantax in its US$1.2 billion acquisition by Cetera.
• Wafra Inc. in connection with a growth equity and debt investment in Spotless Brands, a leading national car wash platform. This investment provided critical support for Spotless’s continued growth and investment strategy. Spotless Brands has over 140 locations in Arizona, Colorado, Oklahoma, Washington, D.C., Maryland, Tennessee, Ohio, West Virginia, and Virginia.
• Incyte in its acquisition of Villaris Therapeutics, a biopharmaceutical company focused on the development of novel antibody therapeutics.
• Clearlake Capital-backed Cornerstone OnDemand, Inc. in its acquisition of SumTotal.
• Clearlake Capital and Motive Partners in the acquisition of BETA+ from London Stock Exchange Group.